Verition Fund Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,900	Closed	-$330K	–	2281
2023 Q3	$330K	Buy	20,900 +900	+5%	+$14.2K	﹤0.01%	1375
2023 Q2	$389K	Buy	+20,000	New	+$389K	0.01%	1186